Johnson & Johnson
Precision medicine, proven outcomes
New Brunswick, New Jersey, U.S.
Johnson & Johnson (J&J) is a global healthcare giant renowned for its extensive range of pharmaceutical, medical device, and consumer health products. The company operates with a unique "dual-engine" strategy, combining innovative medicine and medtech divisions, emphasizing innovation and strategic acquisitions to improve patient outcomes worldwide.
How We Help
Core Technology
Robotics, Artificial Intelligence (AI), Machine Learning, Digital and Data Science solutions, Minimally Invasive Surgical solutions
Key Differentiators
Strong brand reputation, significant financial strength, extensive global reach, deep disease expertise, continuous heavy R&D investment, unique dual-engine structure (pharmaceuticals and medtech), Credo-Based Culture
Clinical Focus
Oncology, Immunology, Neuroscience, Pulmonary Hypertension, Infectious Diseases, Cardiopulmonary, Cardiovascular, Orthopaedics, Surgery, Vision
Target Customers
Hospitals, clinics, pharmacies, healthcare providers, individual consumers
Product Stage
Mature
Company Info
- Business Model
- B2B, B2C
- Founded
- 1886
- Website
- www.jnj.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
27 FDA approvals in 2024. Rybrevant Faspro subcutaneous formulation approved Feb 2026 for EGFR-mutated NSCLC based on phase 3 PALOMA-3 trial. Nipocalimab submitted for myasthenia gravis based on Vivacity-MG3 Phase III program. TREMFYA positive phase 3b APEX data for psoriatic arthritis. 18 positive registrational studies completed in 2024.
MedStartr Index Score
?What do you think of Johnson & Johnson?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.